Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety

被引:32
|
作者
Gao, ZG
Joshi, BV
Klutz, AM
Kim, SK
Lee, HW
Kim, HO
Jeong, LS
Jacobson, KA [1 ]
机构
[1] NIDDKD, Bioorgan Chem Lab, Mol Recognit Sect, NIH, Bethesda, MD 20892 USA
[2] Ewha Womans Univ, Coll Pharm, Med Chem Lab, Seoul 120750, South Korea
基金
美国国家卫生研究院;
关键词
nucleoside; G protein-coupled receptor; adenylyl cyclase; molecular modeling; radioligand binding;
D O I
10.1016/j.bmcl.2005.10.054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The highly selective agonists of the A(3) adenosine receptor (AR), Cl-IB-MECA (2-chloro-N-6-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine), and its 4'-thio analogue, were successfully converted into selective antagonists simply by appending a second N-methyl group on the 5'-uronamide position. The 2-chloro-5'-(N,N-dimethyl)uronamido analogues bound to, but did not activate, the human A(3)AR, with K-i values of 29 nM (4'-O) and 15 nM (4'-S), showing > 100-fold selectivity over A(1), A(2A), and A(2B)ARs. Competitive antagonism was demonstrated by Schild analysis. The 2-(dimethylamino)-5'-(N,N-dimethyl)uronamido substitution also retained A3AR selectivity but lowered affinity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:596 / 601
页数:6
相关论文
共 50 条
  • [41] Divergent Solution-Phase Synthesis of Diarylpyrimidine Libraries as Selective A3 Adenosine Receptor Antagonists
    Yaziji, Vicente
    Coelho, Alberto
    El Maatougui, Abdelaziz
    Brea, Jose
    Isabel Loza, M.
    Garcia-Mera, Xerardo
    Sotelo, Eddy
    JOURNAL OF COMBINATORIAL CHEMISTRY, 2009, 11 (04): : 519 - 522
  • [42] Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor
    Huang, Xianglin
    Chorianopoulou, Anna
    Kalkounou, Panagoula
    Georgiou, Maria
    Pousias, Athanasios
    Davies, Amy
    Pearce, Abigail
    Harris, Matthew
    Lambrinidis, George
    Marakos, Panagiotis
    Pouli, Nicole
    Kolocouris, Antonios
    Lougiakis, Nikolaos
    Ladds, Graham
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (15) : 13117 - 13146
  • [43] A binding kinetics study of human adenosine A3 receptor agonists
    Xia, Lizi
    Kyrizaki, Athina
    Tosh, Dilip K.
    van Duijl, Tirsa T.
    Roorda, Jacomina Cornelia
    Jacobson, Kenneth A.
    Ijzerman, Adriaan P.
    Heitman, Laura H.
    BIOCHEMICAL PHARMACOLOGY, 2018, 153 : 248 - 259
  • [44] Synthesis of 3′-acetamidoadenosine derivatives as potential A3 adenosine receptor agonists
    Chun, Moon Woo
    Choi, Sung Wook
    Kang, Tae Kyung
    Choi, Won Jun
    Kim, Hea Ok
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    Jeong, Lak Shin
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (04): : 408 - 420
  • [45] Affinity prediction on A3 adenosine receptor antagonists: The chemometric approach
    Luan, Feng
    Melo, Andre
    Borges, Fernanda
    Cordeiro, M. Natalia D. S.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) : 6853 - 6859
  • [46] Triazoloquinazolines as human A3 adenosine receptor antagonists: A QSAR study
    Kim, Dooil
    Hong, Suk-In
    Lee, Dae-Sil
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2006, 7 (11): : 485 - 496
  • [47] Recent Advances on A3 Adenosine Receptor Antagonists by QSAR Tools
    Luan, Feng
    Borges, Fernanda
    Cordeiro, M. Natalia D. S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (08) : 878 - 894
  • [48] 2-pyrazolyl-N6-substituted adenosine derivatives as potent and selective A3 adenosine receptor agonists.
    Elzein, E
    Palle, V
    Wu, YZ
    Maa, T
    Zeng, DW
    Zablocki, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U53 - U53
  • [49] A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
    Spinaci, Andrea
    Buccioni, Michela
    Dal Ben, Diego
    Maggi, Federica
    Marucci, Gabriella
    Francucci, Beatrice
    Santoni, Giorgio
    Lambertucci, Catia
    Volpini, Rosaria
    PHARMACEUTICALS, 2022, 15 (02)
  • [50] Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo Efficacy
    Tosh, Dilip K.
    Crane, Steven
    Chen, Zhoumou
    Paoletta, Silvia
    Gao, Zhan-Guo
    Gizewski, Elizabeth
    Auchampach, John A.
    Salvemini, Daniela
    Jacobson, Kenneth A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07): : 804 - 808